Axa
KYNB

Axa’s Kyntra Bio KYNB Stock Holding History

Axa’s Portfolio KYNB Stock Details KYNB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-1,032
Closed -$481K – 1110
2023
Q1 		$481K Sell
1,032
-232
-18% -$123K ﹤0.01% 967
2022
Q4 		$506K Sell
1,264
-7,164
-85% -$2.74M ﹤0.01% 988
2022
Q3 		$2.74M Hold
8,428
– – 0.01% 704
2022
Q2 		$2.22M Buy
+8,428
New +$2.15M 0.01% 755
2018
Q2 		– Sell
-244
Closed -$282K – 1370
2018
Q1 		$282K Buy
+244
New +$321K ﹤0.01% 1269

Other funds holding KYNB

Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Schroder Investment Management Group
Schroder Investment Management Group London, United Kingdom $122B AUM 29.27% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Axa's KYNB Position: Q2 2023 in Review

Axa sold out of Kyntra Bio (KYNB) in Q2 2023, closing a stake of 1,032 shares — an estimated $481K sold.

Axa first reported a position in KYNB in Q1 2018 and held it in 5 quarters. The position peaked at $2.74M in Q3 2022. 152 funds tracked by Wall St. Rank hold KYNB as of Q2 2023.

  • Axa reported no remaining Kyntra Bio position as of Q2 2023 after selling out during the quarter.
  • Axa sold 1,032 Kyntra Bio shares in Q2 2023, an estimated $481K.
  • Axa first reported a position in Kyntra Bio in Q1 2018 and held it in 5 quarters.
  • Axa's Kyntra Bio position peaked at $2.74M in Q3 2022.
  • 152 funds tracked by Wall St. Rank held Kyntra Bio as of Q2 2023.

Based on Axa's 13F filing for Q2 2023, filed 14 Aug 2023.